Beyond Tissue Samples: The Promise of Liquid Biopsy Market in Precision Medicine The liquid biopsy market was estimated at USD 2.83 billion in 2022 and is likely to grow at a CAGR of 17.99% during 2023-2028 to reach USD 7.64 billion in 2028. A liquid biopsy is a minimally invasive medical procedure that involves analyzing a blood sample or other bodily fluids to detect and monitor various diseases, including cancer. Read More: https://www.globenewswire.com/en/news-release/2022/10/06/2529163/0/en/Liquid-Biopsy-Market-is-Projected-to-Reach-US-7-64-Billion-in-2028.html